P F
1 feb, 2021

Policies recently reviewed for annual update

The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com.

  • Allergy Testing
  • Aqueous Shunts and Stents for Glaucoma
  • Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies (Former Title: Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies)
  • Esophageal pH Monitoring
  • Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions
  • Genetic Testing Services
  • Lysis of Epidural Adhesions
  • Non-Wearable Automatic External Defibrillators (AED)
  • Peripheral Artery Disease (PAD) Rehabilitation
  • Prior Authorization Via Web-Based Tool for Durable Medical Equipment (DME)
  • Prior Authorization Via Web-Based Tool for Procedures
  • Semi and Fully Implantable Middle Ear Hearing Aid
  • Sphenopalatine Ganglion Block for Headache
  • TEMPORARY Cost Share Waiver for Treatment of Confirmed Cases of COVID-19 During the COVID-19 Crisis
  • Transesophageal Endoscopic Treatments for Gastroesophageal Reflux Disease
  • Vertebral Fracture Assessment

We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the drop-down “Draft Medical Policies."